Eosinopenia < 100/ μL as a marker of active COVID-19: An observational prospective study.
CONCLUSION: Eosinopenia - <10/μL - and eosinophil/PMN ratio are useful, low-cost, reproducible tools to help diagnose COVID-19, during an epidemic period, in a population of hospitalized patients admitted for suspicion of COVID-19.
PMID: 33468435 [PubMed - as supplied by publisher]
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Outh R, Boutin C, Gueudet P, Suzuki M, Saada M, Aumaître H Tags: J Microbiol Immunol Infect Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Corticosteroid Therapy | COVID-19 | Epidemics | Epidemiology | France Health | Microbiology | SARS | Study